MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+2.26%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$773M
AUM Growth
+$773M
(-8.5%)
Cap. Flow
-$77.8M
Cap. Flow
% of AUM
-10.06%
Top 10 Holdings %
Top 10 Hldgs %
77.44%
Holding
147
New
42
Increased
10
Reduced
17
Closed
69
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$11.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$11.3M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$11.2M |
| 4 |
Birkenstock
BIRK
|
$10.9M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$10M |
Top Sells
| 1 |
AB InBev
BUD
|
$16.4M |
| 2 |
SharkNinja
SN
|
$14.8M |
| 3 |
Kaspi.kz JSC
KSPI
|
$11.2M |
| 4 |
ODDITY Tech
ODD
|
$8.91M |
| 5 |
GE Aerospace
GE
|
$8.43M |
Sector Composition
| 1 | Healthcare | 6.59% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 3.66% |
| 4 | Financials | 3.35% |
| 5 | Consumer Discretionary | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BBB Foods
TBBB
$2.99B
| $3.94M | 0.51% |
165,000
-158,369
| -49% | -$3.78M |
|
27
Perella Weinberg Partners
PWP
$1.33B
| $3.77M | 0.49% |
232,076
-19,990
| -8% | -$325K |
|
28
Super Micro Computer
SMCI
$23.8B
| $3.69M | 0.48% |
4,500
-1,500
| -25% | -$1.23M |
|
29
VSE Corp
VSEC
$3.35B
| $3.61M | 0.47% |
+40,868
| New | +$3.61M |
|
|
TEM
30
Tempus AI, Inc. Class A Common Stock
TEM
$13.3B
| $3.59M | 0.46% |
+102,604
| New | +$3.59M |
|
31
Alkami Technology
ALKT
$2.58B
| $3.28M | 0.42% |
+115,000
| New | +$3.28M |
|
32
GlobalFoundries
GFS
$18.4B
| $3.26M | 0.42% |
+64,500
| New | +$3.26M |
|
33
Roivant Sciences
ROIV
$8.6B
| $3.21M | 0.41% |
303,575
-46,425
| -13% | -$491K |
|
34
Dyne Therapeutics
DYN
$1.92B
| $3M | 0.39% |
85,000
-85,000
| -50% | -$3M |
|
35
Day One Biopharmaceuticals
DAWN
$766M
| $2.76M | 0.36% |
+200,000
| New | +$2.76M |
|
36
Solid Biosciences
SLDB
$448M
| $2.55M | 0.33% |
450,000
-170,000
| -27% | -$964K |
|
|
LB
37
LandBridge Company LLC
LB
$1.35B
| $2.32M | 0.3% |
+100,000
| New | +$2.32M |
|
38
Crescent Energy
CRGY
$2.4B
| $2.25M | 0.29% |
190,000
+14,900
| +9% | +$177K |
|
39
MoonLake Immunotherapeutics
MLTX
$3.78B
| $2.2M | 0.28% |
50,000
-65,000
| -57% | -$2.86M |
|
40
Recursion Pharmaceuticals
RXRX
$2.02B
| $2.18M | 0.28% |
+290,000
| New | +$2.18M |
|
41
UL Solutions
ULS
$12.6B
| $2.11M | 0.27% |
+49,980
| New | +$2.11M |
|
42
CompoSecure
CMPO
$1.94B
| $2.11M | 0.27% |
+310,000
| New | +$2.11M |
|
43
Avidity Biosciences
RNA
$6.12B
| $2.04M | 0.26% |
+50,000
| New | +$2.04M |
|
44
Structure Therapeutics
GPCR
$1.14B
| $1.96M | 0.25% |
50,000
-44,714
| -47% | -$1.76M |
|
45
Peloton Interactive
PTON
$3.1B
| $1.86M | 0.24% |
+550,000
| New | +$1.86M |
|
46
NVIDIA
NVDA
$4.15T
| $1.85M | 0.24% |
15,000
+14,000
| +1,400% | +$618K |
|
47
REV Group
REVG
$2.85B
| $1.62M | 0.21% |
65,000
-193,938
| -75% | -$4.83M |
|
48
Dorian LPG
LPG
$1.3B
| $1.36M | 0.18% |
+32,500
| New | +$1.36M |
|
49
Morgan Stanley Direct Lending Fund
MSDL
$1.56B
| $1.36M | 0.18% |
62,315
-9,897
| -14% | -$216K |
|
50
Humacyte
HUMA
$231M
| $1.34M | 0.17% |
280,000
-720,000
| -72% | -$3.46M |
|